Faricimab efficacy in type 1 macular neovascularization: AI-assisted quantification of pigment epithelium detachment (PED) volume reduction over 12 months in Naïve and switch eyes

Faricimab efficacy in type 1 macular neovascularization: AI-assisted quantification of pigment epithelium detachment (PED) volume reduction over 12 months in Naïve and switch eyes

Abstract Background This study evaluates the efficacy of intravitreal Faricimab in reducing pigment epithelium detachment (PED) and fluid volumes in both treatment-naïve eyes and eyes unresponsive to anti-VEGF mono-therapies, all diagnosed with type 1 macular neovascularization (T1 MNV) over a perio...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Cattaneo, Paolo Forte, Giovanni Forte, Chiara M. Eandi
Format: Article
Language:English
Published: BMC 2025-01-01
Series:International Journal of Retina and Vitreous
Subjects:
Type 1 macular neovascularization
Type 1 MNV
Pigment epithelium detachment
PED
Faricimab
Intravitreal injection
Online Access:https://doi.org/10.1186/s40942-025-00629-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items